Transcription of Supplementary Appendix
{{id}} {{{paragraph}}}
Supplementary AppendixSupplement to: Gottlieb RL, Vaca CE, Paredes R, et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 2022;386:305-15. DOI: Appendix has been provided by the authors to give readers additional information about the Supplementary Appendix to: Early Outpatient Remdesivir to Prevent Progression to Severe Covid-19 Table of Contents: GS-US-540-9012 Study Investigators by Country ..2 GS-US-540-9012 Research and Support Team Members ..6 Figure S1. Patient Disposition ..9 Figure S2. Kaplan-Meier Estimate of Time to Symptom Alleviation as Reported by Covid-19-adapted FLU-PRO Figure S3.
Michele Richardson, Natalie Settele, Jessica Christian PharmD, Dianna Robinson LVN Baylor Scott & White Medical Center – Irving, Irving, Texas …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}